Parkinson’s disease, treatment choice and survival over time
Objectives: We compared Monoamine oxidase B (MAO-B) – and dopamine agonist (DA) monotherapy patients with respect to survival, considering gender, age, first prescriber’s specialty and relevant co-morbidity, and compared their specialist health care contacts and hospitalizations. Methods: With data...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-01-01
|
| Series: | Clinical Parkinsonism & Related Disorders |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S259011252200007X |